JUBILANT.NS - Jubilant Life Sciences Limited

NSE - NSE Real Time Price. Currency in INR
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue3/31/20173/31/20163/31/20153/31/2014
Total Revenue58,614,33057,491,33058,262,47058,033,630
Cost of Revenue19,994,97021,174,77026,617,07032,296,060
Gross Profit38,619,36036,316,56031,645,40025,737,570
Operating Expenses
Research Development----
Selling General and Administrative12,799,48011,673,57011,284,12014,965,600
Non Recurring----
Others12,180,70011,755,67013,457,490482,300
Total Operating Expenses47,881,54048,071,45054,238,22050,546,850
Operating Income or Loss10,732,7909,419,8804,024,2507,486,780
Income from Continuing Operations
Total Other Income/Expenses Net-3,356,370-3,997,650-3,621,010-5,413,950
Earnings Before Interest and Taxes10,732,7909,419,8804,024,2507,486,780
Interest Expense-3,008,370-3,351,750-3,269,680-3,064,170
Income Before Tax7,376,4205,422,230403,2402,072,830
Income Tax Expense1,630,1601,554,000804,840696,440
Minority Interest-392,880-381,330-381,3301,579,350
Net Income From Continuing Ops5,746,2603,868,230-401,6001,376,390
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income5,756,5303,918,310-577,6401,090,400
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares5,756,5303,918,310-577,6401,090,400